![Peter Llewellyn-Davies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Llewellyn-Davies
Directeur/Membre du Conseil chez
SHIELD THERAPEUTICS PLC
Fortune : 14 263 $ au 31/05/2026
Profil
Peter Llewellyn-Davies is the founder of InvIOs GmbH, where he currently holds the title of Chief Executive Officer & Chief Financial Officer since 2022.
He is also the founder of Acceleration Partners LLC.
Additionally, Mr. Llewellyn-Davies currently holds the position of Chief Executive Officer at invIOs Holding AG since 2021, Chairman-Management Board at Biotechnologie-Industrie-Organisation Austria since 2020, Independent Non-Executive Director at Shield Therapeutics Plc since 2016, and Chief Executive & Financial Officer at APEIRON Biologics AG since 2018.
Previously, he held positions such as Executive Director-Finance at Süd-Chemie AG, Managing Director at Müller Dairy (UK) Ltd., Director at Catherex, Inc., Chief Financial Officer & Executive Director at Wilex, Inc., Non-Executive Director at Immunocore Holdings Plc, Member-Supervisory Board at 2invest AG from 2017 to 2021, Chief Financial Officer at CoreOptics GmbH, Chief Financial & Business Officer at MediGene AG from 2012 to 2016, and Chief Financial Officer at Heidelberg Pharma AG from 2010 to 2012.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHIELD THERAPEUTICS PLC 0,02 % | 31/12/2025 | 177 842 ( 0,02 % ) | 14 263 $ | 31/05/2026 |
Postes actifs de Peter Llewellyn-Davies
| Sociétés | Poste | Début |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/02/2016 |
APEIRON Biologics AG
 APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Directeur Général | 15/07/2018 |
invIOs Holding AG | Directeur Général | 01/12/2021 |
Biotechnologie-Industrie-Organisation Austria | Directeur Général | 01/12/2020 |
Anciens postes connus de Peter Llewellyn-Davies
| Sociétés | Poste | Fin |
|---|---|---|
| 2INVEST AG | Directeur/Membre du Conseil | 28/01/2021 |
| MEDIGENE AG | Directeur Financier/CFO | 31/03/2016 |
| HEIDELBERG PHARMA AG | Directeur Financier/CFO | 10/10/2012 |
Acceleration Partners LLC
 Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Operates as a marketing agency | Fondateur | - |
Süd-Chemie AG
 Süd-Chemie AG Chemicals: SpecialtyProcess Industries Manufactures inorganic chemical produtcs | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
2invest AG
 2invest AG Financial ConglomeratesFinance Operates as an investment holding company primarily investing in biotechnology | Finance |
CoreOptics GmbH
 CoreOptics GmbH Electronic Production EquipmentElectronic Technology Develops and manufactures subsystems for optical networking applications | Electronic Technology |
Süd-Chemie AG
Süd-Chemie AG Chemicals: SpecialtyProcess Industries Manufactures inorganic chemical produtcs | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Müller Dairy (UK) Ltd.
 Müller Dairy (UK) Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures and distributes dairy products | Consumer Non-Durables |
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology Develops therapies for cancer immunotherapy and respiratory diseases | Health Technology |
Catherex, Inc.
 Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Wilex, Inc.
 Wilex, Inc. Medical/Nursing ServicesHealth Services Develops medical diagnostic tests | Health Services |
Acceleration Partners LLC
Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Operates as a marketing agency | Commercial Services |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
invIOs Holding AG | |
Biotechnologie-Industrie-Organisation Austria |
